We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+9.85%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.13B
AUM Growth
+$72.2M
Cap. Flow
+$9.62M
Cap. Flow %
0.85%
Top 10 Hldgs %
7.17%
Holding
858
New
204
Increased
192
Reduced
260
Closed
148

Top Buys

Rank Stock Value
1
WMB icon
Williams Companies
WMB
+$4.82M
2
VFC icon
VF Corp
VFC
+$4.71M
3
INSP icon
Inspire Medical Systems
INSP
+$4.06M
4
GLW icon
Corning
GLW
+$3.96M
5
PCRX icon
Pacira BioSciences
PCRX
+$3.94M

Top Sells

Rank Stock Value
1
SPOT icon
Spotify
SPOT
+$7.22M
2
UBER icon
Uber
UBER
+$5.67M
3
TEAM icon
Atlassian
TEAM
+$5.66M
4
HOOD icon
Robinhood
HOOD
+$5.36M
5
NTLA icon
Intellia Therapeutics
NTLA
+$4.9M

Sector Composition

Rank Sector Weight
1 Healthcare 20.98%
2 Technology 20.39%
3 Industrials 14.03%
4 Consumer Discretionary 11.34%
5 Financials 10.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVE icon
376
Cenovus Energy
CVE
$54.2B
$955K 0.08%
+57,111
New +$1.06M
UCTT
377
Ultra Clean Holdings
UCTT
$3.12B
$951K 0.08%
23,806
AZO icon
378
AutoZone
AZO
$51.3B
$945K 0.08%
+300
New +$921K
INVX
379
Innovex International
INVX
$1.8B
$940K 0.08%
+64,048
New +$1.03M
APH icon
380
Amphenol
APH
$185B
$938K 0.08%
+14,400
New +$934K
UMBF icon
381
UMB Financial
UMBF
$11.3B
$937K 0.08%
8,916
-200
-2% -$19.5K
FNKO icon
382
Funko
FNKO
$346M
$934K 0.08%
76,429
-7,524
-9% -$75.7K
KNSA icon
383
Kiniksa Pharmaceuticals
KNSA
$6.23B
$931K 0.08%
+37,242
New +$907K
ALC icon
384
Alcon
ALC
$34B
$916K 0.08%
9,153
-43
-0.5% -$4.04K
SEE
385
DELISTED
Sealed Air
SEE
$904K 0.08%
24,894
-40,385
-62% -$1.41M
RLAY icon
386
Relay Therapeutics
RLAY
$4B
$901K 0.08%
127,272
-99,360
-44% -$742K
RXST icon
387
RxSight
RXST
$254M
$896K 0.08%
+18,129
New +$929K
PLYA
388
DELISTED
Playa Hotels & Resorts
PLYA
$892K 0.08%
115,065
+3,502
+3% +$27.7K
AMPL icon
389
Amplitude
AMPL
$1.18B
$890K 0.08%
99,240
+13,563
+16% +$116K
NVGS icon
390
Navigator Holdings
NVGS
$1.35B
$889K 0.08%
55,325
+22,877
+71% +$373K
UWMC icon
391
UWM Holdings
UWMC
$672M
$883K 0.08%
103,581
+66,773
+181% +$563K
CRCT icon
392
Cricut
CRCT
$1.01B
$881K 0.08%
127,137
+8,022
+7% +$48.1K
FFBC icon
393
First Financial Bancorp
FFBC
$3.55B
$880K 0.08%
34,886
-49
-0.1% -$1.23K
VERV
394
DELISTED
Verve Therapeutics
VERV
$880K 0.08%
181,803
-152,061
-46% -$883K
VITL icon
395
Vital Farms
VITL
$586M
$876K 0.08%
24,966
-4,204
-14% -$149K
RPRX icon
396
Royalty Pharma
RPRX
$26.2B
$875K 0.08%
30,934
-20,502
-40% -$568K
BBT
397
Beacon Financial Corp
BBT
$2.5B
$871K 0.08%
32,327
+20,736
+179% +$542K
ENFN
398
DELISTED
Enfusion, Inc.
ENFN
$867K 0.08%
+91,315
New +$788K
WOOF icon
399
Petco
WOOF
$797M
$865K 0.08%
+190,133
New +$645K
ACIW icon
400
ACI Worldwide
ACIW
$6.12B
$859K 0.08%
+16,868
New +$771K

Similar funds

PDT Partners's Q3 2024 Portfolio in Review

As of Q3 2024, PDT Partners held 858 positions worth $1.13B, up 6.8% from $1.06B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.

PDT Partners's Q3 2024 filing shows 204 new, 192 increased, 260 reduced and 148 closed positions. Its largest new stake was Williams Companies: 109,577 shares worth $5M. The largest sale was Spotify, an estimated $7.22M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.

  • PDT Partners's largest Q3 2024 buy was Williams Companies: 109,577 shares worth $5M.
  • PDT Partners added most to e.l.f. Beauty in Q3 2024, an estimated $3.84M increase.
  • PDT Partners's biggest Q3 2024 reduction was Spotify, cutting an estimated $7.22M.
  • PDT Partners fully exited Atlassian in Q3 2024, selling an estimated $5.66M.
  • PDT Partners's ten largest holdings make up 7.2% of its $1.13B portfolio in Q3 2024.
  • PDT Partners opened 204 new positions and closed 148 in Q3 2024.
  • PDT Partners's portfolio value rose 6.8% quarter-over-quarter to $1.13B.

Based on PDT Partners's 13F filing for Q3 2024, filed 14 Nov 2024.